TRLS.L
Price:
$1.85
Market Cap:
$3.86M
Trellus Health plc provides digital chronic condition management solutions for employers and health plans. The company offers TrellusElevate, a proprietary HIPAA-compliant technology platform to coordinate and deliver personalized care remotely through telemedicine. Its platform provides patients with access to a care team, educational content resources, and remote monitoring capabilities for the treatment of inflammatory bowel diseases, which include the chronic incurable conditions of Crohn's Disease and ulcerative colitis. The company was founded in 2020 and is headquartered in White Plains, New York.[Read more]
Industry
Medical - Healthcare Information Services
IPO Date
2021-05-31
Stock Exchange
LSE
Ticker
TRLS.L
According to Trellus Health plc’s latest financial reports and current stock price. The company's current ROE is -37.95%. This represents a change of 114.11% compared to the average of -17.73% of the last 4 quarters.
The mean historical ROE of Trellus Health plc over the last ten years is -30.06%. The current -37.95% ROE has changed 26.26% with respect to the historical average. Over the past ten years (40 quarters), TRLS.L's ROE was at its highest in in the June 2020 quarter at 0%. The ROE was at its lowest in in the June 2024 quarter at -24.92%.
Average
-30.06%
Median
-33.81%
Minimum
-35.89%
Maximum
-16.73%
Discovering the peaks and valleys of Trellus Health plc ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 109.84%
Maximum Annual ROE = -16.73%
Minimum Annual Increase = -53.38%
Minimum Annual ROE = -35.89%
Year | ROE | Change |
---|---|---|
2023 | -32.51% | -7.42% |
2022 | -35.11% | 109.84% |
2021 | -16.73% | -53.38% |
The current ROE of Trellus Health plc (TRLS.L) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-28.12%
5-year avg
-30.06%
10-year avg
-30.06%
Trellus Health plc’s ROE is greater than Verici Dx plc (-71.67%), less than EKF Diagnostics Holdings plc (7.03%), less than Renalytix Plc (471.01%), greater than Belluscura plc (-102.62%), greater than Poolbeg Pharma PLC (-32.56%),
Company | ROE | Market cap |
---|---|---|
-71.67% | $7.88M | |
7.03% | $97.55M | |
471.01% | $28.15M | |
-102.62% | $5.02M | |
-32.56% | $12.25M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Trellus Health plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Trellus Health plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Trellus Health plc's ROE?
How is the ROE calculated for Trellus Health plc (TRLS.L)?
What is the highest ROE for Trellus Health plc (TRLS.L)?
What is the 3-year average ROE for Trellus Health plc (TRLS.L)?
What is the 5-year average ROE for Trellus Health plc (TRLS.L)?
How does the current ROE for Trellus Health plc (TRLS.L) compare to its historical average?